European Commission Releases Pharmaceutical Anti-Competition Report

Published date06 February 2019
Law FirmGoodwin
Subject MatterCompetition,Mergers,EU,Biosimilars,Pfizer,Information Reports,Antitrust Provisions,Competition Authorities,Drug Pricing,Hospira,Merger Controls,Pharmaceutical Industry

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT